JettLam personal page - To The Moon

JettLam

JettLam

No personal profile

387Follow

9Followers

0Topic

0Badge

2021-06-16

A comment

Volvo Cars to test fossil-free steel from SSAB's HYBRIT venture

2021-04-11

Wow

Sorry, the original content has been removed

05-30

$Marvell Technology(MRVL)$ good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop

05-30

wow what a time will it be if i win the coins

2021-04-11

Leave a comment pls

EU seeks new contract with Pfizer/BioNTech for up to 1.8 billion vaccines from 2022 -EU source

2021-02-28

Damn

Pfizer COVID-19 vaccine reduces transmission after one dose -UK study

05-19

#LUmentum drop poet secured 400M

2021-08-24

Shshsjsnnzhshss

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3569591389124298","uuid":"3569591389124298","gmtCreate":1606497756989,"gmtModify":1613129514509,"name":"JettLam","pinyin":"jettlam","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":9,"headSize":387,"tweetSize":108,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-4","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Tiger Star","description":"Join the tiger community for 2000 days","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.05.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.99%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":569930334037104,"gmtCreate":1780149367898,"gmtModify":1780149371976,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/MRVL\">$Marvell Technology(MRVL)$&nbsp;</a><v-v data-views=\"1\"></v-v> good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop&nbsp; $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop&nbsp;","listText":"<a href=\"https://ttm.financial/S/MRVL\">$Marvell Technology(MRVL)$&nbsp;</a><v-v data-views=\"1\"></v-v> good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop&nbsp; $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop&nbsp;","text":"$Marvell Technology(MRVL)$ good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/569930334037104","isVote":1,"tweetType":1,"viewCount":404,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":569828652123056,"gmtCreate":1780124534438,"gmtModify":1780124537520,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"wow what a time will it be if i win the coins","listText":"wow what a time will it be if i win the coins","text":"wow what a time will it be if i win the coins","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/569828652123056","isVote":1,"tweetType":1,"viewCount":28,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":567731161990456,"gmtCreate":1779635219303,"gmtModify":1779635222916,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"wow","listText":"wow","text":"wow","images":[{"img":"https://community-static.tradeup.com/news/e579154f565d27ddfca5ffa229d74d05","width":"1290","height":"3254"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/567731161990456","isVote":1,"tweetType":1,"viewCount":71,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":565870469935296,"gmtCreate":1779185072127,"gmtModify":1779185075861,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"#LUmentum drop poet secured 400M","listText":"#LUmentum drop poet secured 400M","text":"#LUmentum drop poet secured 400M","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/565870469935296","isVote":1,"tweetType":1,"viewCount":306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834294038,"gmtCreate":1629804729024,"gmtModify":1676530136183,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Shshsjsnnzhshss","listText":"Shshsjsnnzhshss","text":"Shshsjsnnzhshss","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/834294038","isVote":1,"tweetType":1,"viewCount":3090,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":162344418,"gmtCreate":1624037037834,"gmtModify":1703827421739,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Apostafay","listText":"Apostafay","text":"Apostafay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/162344418","isVote":1,"tweetType":1,"viewCount":3105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168912493,"gmtCreate":1623946586112,"gmtModify":1703824416058,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Post a day&nbsp;","listText":"Post a day&nbsp;","text":"Post a day","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168912493","isVote":1,"tweetType":1,"viewCount":3584,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161284972,"gmtCreate":1623928933796,"gmtModify":1703823731183,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Get my post featured pls","listText":"Get my post featured pls","text":"Get my post featured pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/161284972","isVote":1,"tweetType":1,"viewCount":3427,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":169887868,"gmtCreate":1623827841954,"gmtModify":1703820681126,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"A comment","listText":"A comment","text":"A comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/169887868","repostId":"2143762347","repostType":4,"repost":{"id":"2143762347","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623826298,"share":"https://ttm.financial/m/news/2143762347?lang=en_US&edition=fundamental","pubTime":"2021-06-16 14:51","market":"us","language":"en","title":"Volvo Cars to test fossil-free steel from SSAB's HYBRIT venture","url":"https://stock-news.laohu8.com/highlight/detail?id=2143762347","media":"Reuters","summary":"STOCKHOLM, June 16 (Reuters) - Swedish steelmaker SSAB said on Wednesday it had agreed with Volvo Ca","content":"<p>STOCKHOLM, June 16 (Reuters) - Swedish steelmaker SSAB&nbsp;said on Wednesday it had agreed with Volvo Cars to jointly explore the development of fossil-free steel for use in the automotive industry.</p> \n<p>The Swedish carmaker, owned by China's Geely Holding, will be the first car maker to source steel from green steel venture HYBRIT, which is owned by SSAB, Swedish state-owned utility Vattenfall and Swedish miner LKAB.</p> \n<p>\"This steel will be used for testing purposes and may be used in a concept car,\" SSAB said in a statement.</p> \n<p>The HYBRIT project last year began test operations in Sweden to replace coking coal, traditionally needed for ore-based steel making, with fossil-free electricity and hydrogen, which in turn is produced using only renewable power. It aims for a demonstration plant to be ready in 2026.</p> \n<p>\"Together with Volvo Cars, we aim to develop fossil-free steel products for cars of the future,\" SSAB said, adding that Volvo Cars aimed to be the first carmaker to use fossil-free steel for its own actual car production.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Volvo Cars to test fossil-free steel from SSAB's HYBRIT venture</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVolvo Cars to test fossil-free steel from SSAB's HYBRIT venture\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-16 14:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>STOCKHOLM, June 16 (Reuters) - Swedish steelmaker SSAB&nbsp;said on Wednesday it had agreed with Volvo Cars to jointly explore the development of fossil-free steel for use in the automotive industry.</p> \n<p>The Swedish carmaker, owned by China's Geely Holding, will be the first car maker to source steel from green steel venture HYBRIT, which is owned by SSAB, Swedish state-owned utility Vattenfall and Swedish miner LKAB.</p> \n<p>\"This steel will be used for testing purposes and may be used in a concept car,\" SSAB said in a statement.</p> \n<p>The HYBRIT project last year began test operations in Sweden to replace coking coal, traditionally needed for ore-based steel making, with fossil-free electricity and hydrogen, which in turn is produced using only renewable power. It aims for a demonstration plant to be ready in 2026.</p> \n<p>\"Together with Volvo Cars, we aim to develop fossil-free steel products for cars of the future,\" SSAB said, adding that Volvo Cars aimed to be the first carmaker to use fossil-free steel for its own actual car production.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VLVLY":"Volvo AB"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143762347","content_text":"STOCKHOLM, June 16 (Reuters) - Swedish steelmaker SSAB said on Wednesday it had agreed with Volvo Cars to jointly explore the development of fossil-free steel for use in the automotive industry.\nThe Swedish carmaker, owned by China's Geely Holding, will be the first car maker to source steel from green steel venture HYBRIT, which is owned by SSAB, Swedish state-owned utility Vattenfall and Swedish miner LKAB.\n\"This steel will be used for testing purposes and may be used in a concept car,\" SSAB said in a statement.\nThe HYBRIT project last year began test operations in Sweden to replace coking coal, traditionally needed for ore-based steel making, with fossil-free electricity and hydrogen, which in turn is produced using only renewable power. It aims for a demonstration plant to be ready in 2026.\n\"Together with Volvo Cars, we aim to develop fossil-free steel products for cars of the future,\" SSAB said, adding that Volvo Cars aimed to be the first carmaker to use fossil-free steel for its own actual car production.","news_type":1,"symbols_score_info":{"VLVLY":0.9}},"isVote":1,"tweetType":1,"viewCount":4151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185784811,"gmtCreate":1623673838333,"gmtModify":1704208306216,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Psotpsotpost","listText":"Psotpsotpost","text":"Psotpsotpost","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/185784811","isVote":1,"tweetType":1,"viewCount":2972,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":181867947,"gmtCreate":1623385519989,"gmtModify":1704202227248,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Postafaything","listText":"Postafaything","text":"Postafaything","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/181867947","isVote":1,"tweetType":1,"viewCount":3396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183366354,"gmtCreate":1623308960778,"gmtModify":1704200568282,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Post a day&nbsp;","listText":"Post a day&nbsp;","text":"Post a day","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183366354","isVote":1,"tweetType":1,"viewCount":3041,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180551862,"gmtCreate":1623214321756,"gmtModify":1704198520480,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Postssssss","listText":"Postssssss","text":"Postssssss","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/180551862","isVote":1,"tweetType":1,"viewCount":3271,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":117430066,"gmtCreate":1623156001955,"gmtModify":1704197213752,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Post a day sends coins","listText":"Post a day sends coins","text":"Post a day sends coins","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117430066","isVote":1,"tweetType":1,"viewCount":2820,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114245377,"gmtCreate":1623077218099,"gmtModify":1704195643566,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Postpostpost","listText":"Postpostpost","text":"Postpostpost","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/114245377","isVote":1,"tweetType":1,"viewCount":1093,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":116843455,"gmtCreate":1622792423177,"gmtModify":1704191267648,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Post a dat","listText":"Post a dat","text":"Post a dat","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/116843455","isVote":1,"tweetType":1,"viewCount":1635,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":118324389,"gmtCreate":1622720190041,"gmtModify":1704189646798,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Ahhhhhhhhhh","listText":"Ahhhhhhhhhh","text":"Ahhhhhhhhhh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/118324389","isVote":1,"tweetType":1,"viewCount":1460,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":113515294,"gmtCreate":1622625804818,"gmtModify":1704187571335,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Abahahahhahaha","listText":"Abahahahhahaha","text":"Abahahahhahaha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/113515294","isVote":1,"tweetType":1,"viewCount":2160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":119131468,"gmtCreate":1622525586654,"gmtModify":1704185639548,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Boooooost","listText":"Boooooost","text":"Boooooost","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/119131468","isVote":1,"tweetType":1,"viewCount":1210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":137663710,"gmtCreate":1622343837330,"gmtModify":1704183238451,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Dipsdipsdils","listText":"Dipsdipsdils","text":"Dipsdipsdils","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/137663710","isVote":1,"tweetType":1,"viewCount":1447,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":169887868,"gmtCreate":1623827841954,"gmtModify":1703820681126,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"A comment","listText":"A comment","text":"A comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/169887868","repostId":"2143762347","repostType":4,"repost":{"id":"2143762347","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623826298,"share":"https://ttm.financial/m/news/2143762347?lang=en_US&edition=fundamental","pubTime":"2021-06-16 14:51","market":"us","language":"en","title":"Volvo Cars to test fossil-free steel from SSAB's HYBRIT venture","url":"https://stock-news.laohu8.com/highlight/detail?id=2143762347","media":"Reuters","summary":"STOCKHOLM, June 16 (Reuters) - Swedish steelmaker SSAB said on Wednesday it had agreed with Volvo Ca","content":"<p>STOCKHOLM, June 16 (Reuters) - Swedish steelmaker SSAB&nbsp;said on Wednesday it had agreed with Volvo Cars to jointly explore the development of fossil-free steel for use in the automotive industry.</p> \n<p>The Swedish carmaker, owned by China's Geely Holding, will be the first car maker to source steel from green steel venture HYBRIT, which is owned by SSAB, Swedish state-owned utility Vattenfall and Swedish miner LKAB.</p> \n<p>\"This steel will be used for testing purposes and may be used in a concept car,\" SSAB said in a statement.</p> \n<p>The HYBRIT project last year began test operations in Sweden to replace coking coal, traditionally needed for ore-based steel making, with fossil-free electricity and hydrogen, which in turn is produced using only renewable power. It aims for a demonstration plant to be ready in 2026.</p> \n<p>\"Together with Volvo Cars, we aim to develop fossil-free steel products for cars of the future,\" SSAB said, adding that Volvo Cars aimed to be the first carmaker to use fossil-free steel for its own actual car production.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Volvo Cars to test fossil-free steel from SSAB's HYBRIT venture</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVolvo Cars to test fossil-free steel from SSAB's HYBRIT venture\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-16 14:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>STOCKHOLM, June 16 (Reuters) - Swedish steelmaker SSAB&nbsp;said on Wednesday it had agreed with Volvo Cars to jointly explore the development of fossil-free steel for use in the automotive industry.</p> \n<p>The Swedish carmaker, owned by China's Geely Holding, will be the first car maker to source steel from green steel venture HYBRIT, which is owned by SSAB, Swedish state-owned utility Vattenfall and Swedish miner LKAB.</p> \n<p>\"This steel will be used for testing purposes and may be used in a concept car,\" SSAB said in a statement.</p> \n<p>The HYBRIT project last year began test operations in Sweden to replace coking coal, traditionally needed for ore-based steel making, with fossil-free electricity and hydrogen, which in turn is produced using only renewable power. It aims for a demonstration plant to be ready in 2026.</p> \n<p>\"Together with Volvo Cars, we aim to develop fossil-free steel products for cars of the future,\" SSAB said, adding that Volvo Cars aimed to be the first carmaker to use fossil-free steel for its own actual car production.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VLVLY":"Volvo AB"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143762347","content_text":"STOCKHOLM, June 16 (Reuters) - Swedish steelmaker SSAB said on Wednesday it had agreed with Volvo Cars to jointly explore the development of fossil-free steel for use in the automotive industry.\nThe Swedish carmaker, owned by China's Geely Holding, will be the first car maker to source steel from green steel venture HYBRIT, which is owned by SSAB, Swedish state-owned utility Vattenfall and Swedish miner LKAB.\n\"This steel will be used for testing purposes and may be used in a concept car,\" SSAB said in a statement.\nThe HYBRIT project last year began test operations in Sweden to replace coking coal, traditionally needed for ore-based steel making, with fossil-free electricity and hydrogen, which in turn is produced using only renewable power. It aims for a demonstration plant to be ready in 2026.\n\"Together with Volvo Cars, we aim to develop fossil-free steel products for cars of the future,\" SSAB said, adding that Volvo Cars aimed to be the first carmaker to use fossil-free steel for its own actual car production.","news_type":1,"symbols_score_info":{"VLVLY":0.9}},"isVote":1,"tweetType":1,"viewCount":4151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346756476,"gmtCreate":1618116815495,"gmtModify":1704706767905,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/346756476","repostId":"1142324412","repostType":4,"isVote":1,"tweetType":1,"viewCount":1360,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":569930334037104,"gmtCreate":1780149367898,"gmtModify":1780149371976,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/MRVL\">$Marvell Technology(MRVL)$&nbsp;</a><v-v data-views=\"1\"></v-v> good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop&nbsp; $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop&nbsp;","listText":"<a href=\"https://ttm.financial/S/MRVL\">$Marvell Technology(MRVL)$&nbsp;</a><v-v data-views=\"1\"></v-v> good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop&nbsp; $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop&nbsp;","text":"$Marvell Technology(MRVL)$ good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop $Marvell Technology(MRVL)$ Bullish good buy good early buy good buy buy buy if h don't buy just buy and buy more don't stop","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/569930334037104","isVote":1,"tweetType":1,"viewCount":404,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":569828652123056,"gmtCreate":1780124534438,"gmtModify":1780124537520,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"wow what a time will it be if i win the coins","listText":"wow what a time will it be if i win the coins","text":"wow what a time will it be if i win the coins","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/569828652123056","isVote":1,"tweetType":1,"viewCount":28,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346752925,"gmtCreate":1618116829967,"gmtModify":1704706768392,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Leave a comment pls","listText":"Leave a comment pls","text":"Leave a comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/346752925","repostId":"2126038125","repostType":4,"repost":{"id":"2126038125","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1617981432,"share":"https://ttm.financial/m/news/2126038125?lang=en_US&edition=fundamental","pubTime":"2021-04-09 23:17","market":"us","language":"en","title":"EU seeks new contract with Pfizer/BioNTech for up to 1.8 billion vaccines from 2022 -EU source","url":"https://stock-news.laohu8.com/highlight/detail?id=2126038125","media":"Reuters","summary":"BRUSSELS, April 9 (Reuters) - The European Commission is seeking EU governments’ approval to launch ","content":"<p>BRUSSELS, April 9 (Reuters) - The European Commission is seeking EU governments’ approval to launch talks with Pfizer and BioNTech for the purchase of up to 1.8 billion doses of their COVID-19 vaccines to be delivered in 2022 and 2023, an EU official told Reuters.</p>\n<p>Earlier on Friday, German daily Die Welt reported that the Commission was shortly to sign contracts to buy up to 1.8 billion doses, but did not say with which company.</p>\n<p>The EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer-BioNTech and that EU governments backed the plan, though there was not yet a definitive approval.</p>\n<p>A Commission spokesman confirmed plans to buy the additional doses, of which half would be optional.</p>\n<p>He also confirmed that the EU executive had already identified one supplier, a manufacturer of mRNA vaccines, but declined to comment on which company would be approached to negotiate the contract.</p>\n<p>“If provided the opportunity Pfizer and BioNTech are prepared to supply Europe with hundreds of millions of doses of COVID vaccines in 2022 and 2023 produced in our manufacturing facilities in Europe,” a Pfizer spokesman said.</p>\n<p>The two companies have the capacity to produce more than 3 billion doses of vaccine in 2022, he added.</p>\n<p>Pfizer-BioNTech and Moderna are already supplying the EU with mRNA vaccines and German biotech firm CureVac is seeking EU approval for its mRNA shot.</p>\n<p>The vaccines would be delivered under monthly timetables and with clauses obliging the supplier to deliver, the EU official said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU seeks new contract with Pfizer/BioNTech for up to 1.8 billion vaccines from 2022 -EU source</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU seeks new contract with Pfizer/BioNTech for up to 1.8 billion vaccines from 2022 -EU source\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-09 23:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BRUSSELS, April 9 (Reuters) - The European Commission is seeking EU governments’ approval to launch talks with Pfizer and BioNTech for the purchase of up to 1.8 billion doses of their COVID-19 vaccines to be delivered in 2022 and 2023, an EU official told Reuters.</p>\n<p>Earlier on Friday, German daily Die Welt reported that the Commission was shortly to sign contracts to buy up to 1.8 billion doses, but did not say with which company.</p>\n<p>The EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer-BioNTech and that EU governments backed the plan, though there was not yet a definitive approval.</p>\n<p>A Commission spokesman confirmed plans to buy the additional doses, of which half would be optional.</p>\n<p>He also confirmed that the EU executive had already identified one supplier, a manufacturer of mRNA vaccines, but declined to comment on which company would be approached to negotiate the contract.</p>\n<p>“If provided the opportunity Pfizer and BioNTech are prepared to supply Europe with hundreds of millions of doses of COVID vaccines in 2022 and 2023 produced in our manufacturing facilities in Europe,” a Pfizer spokesman said.</p>\n<p>The two companies have the capacity to produce more than 3 billion doses of vaccine in 2022, he added.</p>\n<p>Pfizer-BioNTech and Moderna are already supplying the EU with mRNA vaccines and German biotech firm CureVac is seeking EU approval for its mRNA shot.</p>\n<p>The vaccines would be delivered under monthly timetables and with clauses obliging the supplier to deliver, the EU official said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126038125","content_text":"BRUSSELS, April 9 (Reuters) - The European Commission is seeking EU governments’ approval to launch talks with Pfizer and BioNTech for the purchase of up to 1.8 billion doses of their COVID-19 vaccines to be delivered in 2022 and 2023, an EU official told Reuters.\nEarlier on Friday, German daily Die Welt reported that the Commission was shortly to sign contracts to buy up to 1.8 billion doses, but did not say with which company.\nThe EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer-BioNTech and that EU governments backed the plan, though there was not yet a definitive approval.\nA Commission spokesman confirmed plans to buy the additional doses, of which half would be optional.\nHe also confirmed that the EU executive had already identified one supplier, a manufacturer of mRNA vaccines, but declined to comment on which company would be approached to negotiate the contract.\n“If provided the opportunity Pfizer and BioNTech are prepared to supply Europe with hundreds of millions of doses of COVID vaccines in 2022 and 2023 produced in our manufacturing facilities in Europe,” a Pfizer spokesman said.\nThe two companies have the capacity to produce more than 3 billion doses of vaccine in 2022, he added.\nPfizer-BioNTech and Moderna are already supplying the EU with mRNA vaccines and German biotech firm CureVac is seeking EU approval for its mRNA shot.\nThe vaccines would be delivered under monthly timetables and with clauses obliging the supplier to deliver, the EU official said.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":1408,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":366591556,"gmtCreate":1614503616175,"gmtModify":1704772140059,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Damn&nbsp;","listText":"Damn&nbsp;","text":"Damn","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/366591556","repostId":"2114371822","repostType":4,"repost":{"id":"2114371822","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1614335051,"share":"https://ttm.financial/m/news/2114371822?lang=en_US&edition=fundamental","pubTime":"2021-02-26 18:24","market":"us","language":"en","title":"Pfizer COVID-19 vaccine reduces transmission after one dose -UK study","url":"https://stock-news.laohu8.com/highlight/detail?id=2114371822","media":"Reuters","summary":"LONDON, Feb 26  - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.Researchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare ","content":"<p>LONDON, Feb 26 (Reuters) - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.</p>\n<p>Researchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.</p>\n<p>“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare workers after a single dose of the Pfizer-BioNTech vaccine,” said Nick Jones, an infectious diseases specialist at Cambridge University Hospital, who co-led the study.</p>\n<p>After separating the test results from unvaccinated and vaccinated staff, Jones’ team found that 0.80% tests from unvaccinated healthcare workers were positive.</p>\n<p>This compared with 0.37% of tests from staff less than 12 days post-vaccination - when the vaccine’s protective effect is not yet fully established - and 0.20% of tests from staff at 12 days or more post-vaccination.</p>\n<p>The study and its results have yet to be independently peer-reviewed by other scientists, but were published online as a preprint on Friday.</p>\n<p>This suggests a four-fold decrease in the risk of asymptomatic COVID-19 infection amongst healthcare workers who have been vaccinated for more than 12 days, and 75% protection, said Mike Weekes, an infectious disease specialist at Cambridge University’s department of medicine, who co-led the study.</p>\n<p>The level of asymptomatic infection was also halved in those vaccinated for less than 12 days, he said.</p>\n<p>Britain has been rolling out vaccinations with both the Pfizer COVID-19 shot and one from AstraZeneca since late December 2020.</p>\n<p>“This is great news – the Pfizer vaccine not only provides protection against becoming ill from SARS-CoV-2, but also helps prevent infection, reducing the potential for the virus to be passed on to others,” Weeks said. “But we have to remember that the vaccine doesn’t give complete protection for everyone.”</p>\n<p>Key real-world data published on Wednesday from Israel, which has conducted one of the world’s fastest rollouts of Pfizer’s COVID-19 vaccine, showed that two doses of the Pfizer shot cut symptomatic COVID-19 cases by 94% across all age groups, and severe illnesses by nearly as much.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer COVID-19 vaccine reduces transmission after one dose -UK study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer COVID-19 vaccine reduces transmission after one dose -UK study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-26 18:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LONDON, Feb 26 (Reuters) - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.</p>\n<p>Researchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.</p>\n<p>“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare workers after a single dose of the Pfizer-BioNTech vaccine,” said Nick Jones, an infectious diseases specialist at Cambridge University Hospital, who co-led the study.</p>\n<p>After separating the test results from unvaccinated and vaccinated staff, Jones’ team found that 0.80% tests from unvaccinated healthcare workers were positive.</p>\n<p>This compared with 0.37% of tests from staff less than 12 days post-vaccination - when the vaccine’s protective effect is not yet fully established - and 0.20% of tests from staff at 12 days or more post-vaccination.</p>\n<p>The study and its results have yet to be independently peer-reviewed by other scientists, but were published online as a preprint on Friday.</p>\n<p>This suggests a four-fold decrease in the risk of asymptomatic COVID-19 infection amongst healthcare workers who have been vaccinated for more than 12 days, and 75% protection, said Mike Weekes, an infectious disease specialist at Cambridge University’s department of medicine, who co-led the study.</p>\n<p>The level of asymptomatic infection was also halved in those vaccinated for less than 12 days, he said.</p>\n<p>Britain has been rolling out vaccinations with both the Pfizer COVID-19 shot and one from AstraZeneca since late December 2020.</p>\n<p>“This is great news – the Pfizer vaccine not only provides protection against becoming ill from SARS-CoV-2, but also helps prevent infection, reducing the potential for the virus to be passed on to others,” Weeks said. “But we have to remember that the vaccine doesn’t give complete protection for everyone.”</p>\n<p>Key real-world data published on Wednesday from Israel, which has conducted one of the world’s fastest rollouts of Pfizer’s COVID-19 vaccine, showed that two doses of the Pfizer shot cut symptomatic COVID-19 cases by 94% across all age groups, and severe illnesses by nearly as much.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2114371822","content_text":"LONDON, Feb 26 (Reuters) - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.\nResearchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.\n“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare workers after a single dose of the Pfizer-BioNTech vaccine,” said Nick Jones, an infectious diseases specialist at Cambridge University Hospital, who co-led the study.\nAfter separating the test results from unvaccinated and vaccinated staff, Jones’ team found that 0.80% tests from unvaccinated healthcare workers were positive.\nThis compared with 0.37% of tests from staff less than 12 days post-vaccination - when the vaccine’s protective effect is not yet fully established - and 0.20% of tests from staff at 12 days or more post-vaccination.\nThe study and its results have yet to be independently peer-reviewed by other scientists, but were published online as a preprint on Friday.\nThis suggests a four-fold decrease in the risk of asymptomatic COVID-19 infection amongst healthcare workers who have been vaccinated for more than 12 days, and 75% protection, said Mike Weekes, an infectious disease specialist at Cambridge University’s department of medicine, who co-led the study.\nThe level of asymptomatic infection was also halved in those vaccinated for less than 12 days, he said.\nBritain has been rolling out vaccinations with both the Pfizer COVID-19 shot and one from AstraZeneca since late December 2020.\n“This is great news – the Pfizer vaccine not only provides protection against becoming ill from SARS-CoV-2, but also helps prevent infection, reducing the potential for the virus to be passed on to others,” Weeks said. “But we have to remember that the vaccine doesn’t give complete protection for everyone.”\nKey real-world data published on Wednesday from Israel, which has conducted one of the world’s fastest rollouts of Pfizer’s COVID-19 vaccine, showed that two doses of the Pfizer shot cut symptomatic COVID-19 cases by 94% across all age groups, and severe illnesses by nearly as much.","news_type":1,"symbols_score_info":{"AONE.U":0.9,"PFE":0.9,"AONE":0.9}},"isVote":1,"tweetType":1,"viewCount":1131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":565870469935296,"gmtCreate":1779185072127,"gmtModify":1779185075861,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"#LUmentum drop poet secured 400M","listText":"#LUmentum drop poet secured 400M","text":"#LUmentum drop poet secured 400M","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/565870469935296","isVote":1,"tweetType":1,"viewCount":306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834294038,"gmtCreate":1629804729024,"gmtModify":1676530136183,"author":{"id":"3569591389124298","authorId":"3569591389124298","name":"JettLam","avatar":"https://static.tigerbbs.com/8d251c4e63016669411c6250ec2f2c02","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569591389124298","idStr":"3569591389124298"},"themes":[],"title":"","htmlText":"Shshsjsnnzhshss","listText":"Shshsjsnnzhshss","text":"Shshsjsnnzhshss","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/834294038","isVote":1,"tweetType":1,"viewCount":3090,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}